S&P Futures
4,307.00 -0.75 (-0.02%) Dow Futures
34,124.00 +6.00 (+0.02%) Nasdaq Futures
13,644.75 -13.50 (-0.10%) Russell 2000 Futures
2,023.80 +0.50 (+0.02%) Crude Oil
86.98 +0.45 (+0.52%) Gold
1,790.50 +0.80 (+0.04%)
AC Immune SA (ACIU)
After hours:
Chart Events
Performance Outlook
| Previous Close | 3.6400 |
| Open | 3.5800 |
| Bid | 3.1200 x 900 |
| Ask | 3.5600 x 3000 |
| Day's Range | 3.4037 - 3.5800 |
| 52 Week Range | 2.0600 - 12.6100 |
| Volume | |
| Avg. Volume | 79,924 |
| Market Cap | 252.105M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.0700 |
| Earnings Date | Apr 26, 2022 - May 02, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.49 |
- GlobeNewswire
AC Immune to Host Key Opinion Leader Webinar on Vaccinations to Treat and Prevent Alzheimer’s and Parkinson’s Diseases
Webinar to take place on Wednesday, August 24th at 10:00 AM ET / 4:00 PM CETDiscussion to focus on novel therapeutic approaches and the selection of biomarkers and target proteins for active vaccination approaches LAUSANNE, Switzerland, Aug. 11, 2022 (GLOBE NEWSWIRE) -- AC Immune SA (Nasdaq: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it will host a key opinion leader (KOL) webinar on vaccinations to treat a
- GlobeNewswire
Detailed Data From the Phase II Crenezumab Alzheimer’s Prevention Initiative Study in Autosomal Dominant Alzheimer’s Disease Presented at AAIC
Crenezumab was safe and well tolerated with no cases of ARIA-E observed during the up to eight-year studyAs previously reported, numerical differences favoring crenezumab over placebo were confirmed across the co-primary, multiple secondary and exploratory endpoints, none statistically significantDemographic and baseline biomarker data indicate a confluence of factors which may have caused the study to have lower than expected statistical powerAll mutation carriers may continue to receive crenez
- Simply Wall St.
What Type Of Shareholders Own The Most Number of AC Immune SA (NASDAQ:ACIU) Shares?
A look at the shareholders of AC Immune SA ( NASDAQ:ACIU ) can tell us which group is most powerful. Institutions will...
